AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15563049 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 75
Study 15563049 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 75
Study 15563049 — intervention group
Group type: COMPARATOR
Intervention: Psychiatric patients
Number of subjects: 75
Study 11352208 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of base-rate changes
Number of subjects: 0
Study 11352208 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory capacity
Number of subjects: 0
Study 11352208 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated working memory load
Number of subjects: 0
Study 9626231 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone plus prednisone (M + P)
Number of subjects: 161
Study 9626231 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone (P)
Number of subjects: 161
Study 7887099 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (n = 20)
Number of subjects: 56
Study 7887099 — intervention group
Group type: COMPARATOR
Intervention: Halothane (n = 19)
Number of subjects: 56
Study 7887099 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (n = 17)
Number of subjects: 56
Study 3269553 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic conflict-centered therapy (n = 34)
Number of subjects: 87
Study 3269553 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centered therapy (n = 34)
Number of subjects: 87
Study 3269553 — intervention group
Group type: COMPARATOR
Intervention: Nontreated control group (n = 19)
Number of subjects: 87
Study 29623516 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine (L-T4) treatment (0.5-3.0 g/(kg·d))
Number of subjects: 64
Study 29623516 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-L-T4 treatment)
Number of subjects: 64
Study 27194097 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-pharmacist collaborative care
Number of subjects: 56
Study 27194097 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 56
Study 25001365 — intervention group
Group type: EXPERIMENTAL
Intervention: High neck circumference (NC)
Number of subjects: 2318
Study 25001365 — intervention group
Group type: EXPERIMENTAL
Intervention: High neck circumference (NC) among hypertensive individuals
Number of subjects: 2318
Study 25001365 — intervention group
Group type: EXPERIMENTAL
Intervention: High neck circumference (NC) among non-hypertensive individuals
Number of subjects: 2318
Study 22275738 — intervention group
Group type: EXPERIMENTAL
Intervention: CartoSound module with SoundStar ICE catheter for pulmonary vein isolation
Number of subjects: 8
Study 20699743 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII
Number of subjects: 0
Study 20699743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18268081 — intervention group
Group type: COMPARATOR
Intervention: OPT-80 (100, 200, 300, and 450 mg)
Number of subjects: 40
Study 18268081 — intervention group
Group type: COMPARATOR
Intervention: OPT-80 (150, 300, or 450 mg)
Number of subjects: 40
Study 18268081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15707996 — intervention group
Group type: EXPERIMENTAL
Intervention: G11778A mutation in ND4 gene
Number of subjects: 38
Study 15707996 — intervention group
Group type: COMPARATOR
Intervention: Mitochondrial genome analysis
Number of subjects: 38
Study 15707996 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete penetrance of LHON
Number of subjects: 38
Study 15707996 — intervention group
Group type: EXPERIMENTAL
Intervention: Other mtDNA variants
Number of subjects: 38
Study 15707996 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear modifier gene(s) or environmental factor(s)
Number of subjects: 38
Study 15259402 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia with Lewy bodies (DLB)
Number of subjects: 59
Study 15259402 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease (AD)
Number of subjects: 59
Study 15259402 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 59
Study 10467831 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortnightly education talk on hand‐washing and skin hygiene (Group 1, n = 70)
Number of subjects: 154
Study 10467831 — intervention group
Group type: COMPARATOR
Intervention: Fortnightly education talk on family planning (Group 2, n = 84)
Number of subjects: 154
Study 10467831 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education programme (1981-1994)
Number of subjects: 154
Study 8543232 — intervention group
Group type: EXPERIMENTAL
Intervention: Dead Sea bath salts (Group I)
Number of subjects: 26
Study 8543232 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (Group II)
Number of subjects: 26
Study 2794095 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CH)
Number of subjects: 0
Study 2794095 — intervention group
Group type: COMPARATOR
Intervention: Sodium lauryl sulfate (SLS)
Number of subjects: 0
Study 797427 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (4,000 rads in 4 weeks) plus radical cystectomy
Number of subjects: 189
Study 797427 — intervention group
Group type: COMPARATOR
Intervention: Radical irradiation (6,000 rads in 6 weeks)
Number of subjects: 189
Study 29866386 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent vouchers (CV) for smoking abstinence (twice‐daily carbon monoxide [CO] readings)
Number of subjects: 184
Study 29866386 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent vouchers (CV) for smoking abstinence
Number of subjects: 184
Study 29866386 — intervention group
Group type: COMPARATOR
Intervention: Non-contingent vouchers (NV) plus counseling to motivate smoking cessation
Number of subjects: 184
Study 27181260 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve Growth Factor (NGF) with corticosteroids, injected intramuscularly at 18μg once a day for 2 months.
Number of subjects: 28
Study 27181260 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids with gradually reduced dosage (control group).
Number of subjects: 28
Study 25043685 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment during DCCT
Number of subjects: 1441
Study 25043685 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment during DCCT
Number of subjects: 1441
Study 22897408 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g activated charcoal by mouth every 4 hours
Number of subjects: 17
Study 22897408 — intervention group
Group type: COMPARATOR
Intervention: No activated charcoal (control)
Number of subjects: 17
Study 21280423 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental stannous-containing dentifrice
Number of subjects: 96
Study 21280423 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total (non-staining marketed triclosan dentifrice)
Number of subjects: 96
Study 21280423 — intervention group
Group type: COMPARATOR
Intervention: Crest Gum Care (0.454% stannous fluoride dentifrice)
Number of subjects: 96
Study 18425074 — intervention group
Group type: EXPERIMENTAL
Intervention: White mineral trioxide aggregate (MTA)
Number of subjects: 46
Study 18425074 — intervention group
Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 46
Study 15973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased central pressure augmentation (AG)
Number of subjects: 228
Study 15973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic systolic blood pressure
Number of subjects: 228
Study 15973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 228
Study 15973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes duration
Number of subjects: 228
Study 15973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased AG (adjusted for sex, age and heart rate)
Number of subjects: 228
Study 14507948 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer testing followed by ultrasound imaging unless D-dimer test was negative and clinically unlikely for DVT
Number of subjects: 1096
Study 14507948 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound imaging alone (control group)
Number of subjects: 1096
Study 14507948 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer testing
Number of subjects: 1096
Study 10650901 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose loperamide (initial dose of 4 mg followed by 4 mg every 8 h, total dose 16 mg/24 h)
Number of subjects: 37
Study 10650901 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose loperamide
Number of subjects: 37
Study 9192198 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium diet (300 mmol/d)
Number of subjects: 22
Study 9192198 — intervention group
Group type: COMPARATOR
Intervention: Low sodium diet (50 mmol/d)
Number of subjects: 22
Study 8458449 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH-a (buserelin acetate, goserelin, nafarelin acetate)
Number of subjects: 130
Study 3947491 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar extradural analgesia with 0.5% bupivacaine (Group I)
Number of subjects: 20
Study 3947491 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia with spontaneous respiration, using 60% nitrous oxide and 1‐2% halothane in oxygen (Group II)
Number of subjects: 20
Study 31278755 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pH (4.0)
Number of subjects: 0
Study 31278755 — intervention group
Group type: COMPARATOR
Intervention: Normal pH (6.0)
Number of subjects: 0
Study 29604181 — intervention group
Group type: EXPERIMENTAL
Intervention: Default online shopping cart containing a nutritionally balanced selection of groceries (n=18)
Number of subjects: 59
Study 29604181 — intervention group
Group type: COMPARATOR
Intervention: Education about nutrition (n=24)
Number of subjects: 59
Study 29604181 — intervention group
Group type: COMPARATOR
Intervention: $10 incentive for selecting nutritious groceries (n=17)
Number of subjects: 59
Study 27835977 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 50
Study 27835977 — intervention group
Group type: COMPARATOR
Intervention: Conventional Training (CT)
Number of subjects: 50
Study 24977755 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (BB)
Number of subjects: 45
Study 24977755 — intervention group
Group type: COMPARATOR
Intervention: Control (no BB)
Number of subjects: 45
Study 22367416 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (n=8) - 10-week hip strengthening programme, twice weekly
Number of subjects: 16
Study 22367416 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=8) - usual activities
Number of subjects: 16
Study 20152960 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help
Number of subjects: 88
Study 20152960 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail therapy
Number of subjects: 88
Study 20152960 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 88
Study 18582372 — intervention group
Group type: EXPERIMENTAL
Intervention: Salpingostomy
Number of subjects: 100
Study 18582372 — intervention group
Group type: COMPARATOR
Intervention: Salpingectomy
Number of subjects: 100
Study 15786902 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insertion
Number of subjects: 307
Study 11265923 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (Comb)
Number of subjects: 579
Study 11265923 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication management (MedMgt)
Number of subjects: 579
Study 11265923 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment (Beh)
Number of subjects: 579
Study 11265923 — intervention group
Group type: COMPARATOR
Intervention: Routine community care (CC)
Number of subjects: 579
Study 11265923 — intervention group
Group type: COMPARATOR
Intervention: Intensive behavioral treatment (Beh)
Number of subjects: 579
Study 9505740 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (0.02, 0.025, or 0.03 mg kg‐1)
Number of subjects: 60
Study 9505740 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium (0.075, 0.01, or 0.0125 mg.kg‐1)
Number of subjects: 60
Study 9505740 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 1 x ED95 of vecuronium + 1 x ED95 of atracurium
Number of subjects: 60
Study 9505740 — intervention group
Group type: COMPARATOR
Intervention: Control group (2 x ED95 of vecuronium or atracurium)
Number of subjects: 60
Study 7849235 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime 1500 mg IV
Number of subjects: 30
Study 7849235 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime 1000 mg IV
Number of subjects: 30
Study 7849235 — intervention group
Group type: COMPARATOR
Intervention: Flucloxacillin 2000 mg IV
Number of subjects: 30
Study 7849235 — intervention group
Group type: COMPARATOR
Intervention: Flucloxacillin 1500 mg IV
Number of subjects: 30
Study 7849235 — intervention group
Group type: COMPARATOR
Intervention: Flucloxacillin 1000 mg IV
Number of subjects: 30
Study 3404136 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 30
Study 3404136 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation
Number of subjects: 30
Study 3404136 — intervention group
Group type: COMPARATOR
Intervention: Neutral Control
Number of subjects: 30
Study 1437767 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate (Zincteral) 200 mg 4 times daily for 12 months
Number of subjects: 9
Study 1437767 — intervention group
Group type: COMPARATOR
Intervention: D-penicillamine (Cuprenil-Polfa) 1.0-1.5 g daily
Number of subjects: 9
Study 360760 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 8-4650
Number of subjects: 37
Study 360760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 31598823 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous phenylephrine (PE) bolus of 1 µg kg−1
Number of subjects: 28
Study 31122111 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Circuit Training plus 10-week home program (FCT-PA)
Number of subjects: 111
Study 31122111 — intervention group
Group type: COMPARATOR
Intervention: Functional Circuit Training plus Health Education (FCT-HE)
Number of subjects: 111
Study 31122111 — intervention group
Group type: COMPARATOR
Intervention: Flexibility and Toning plus Health Education (FT-HE)
Number of subjects: 111
Study 29714870 — intervention group
Group type: EXPERIMENTAL
Intervention: Left lateral position for 15 minutes before turning to supine position
Number of subjects: 60
Study 29714870 — intervention group
Group type: COMPARATOR
Intervention: Supine position immediately after spinal anesthesia
Number of subjects: 60
Study 25828745 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypomethylating agents (HMA) therapy (median of 12 courses, range 1-24)
Number of subjects: 16
Study 25828745 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypomethylating agents (HMA) therapy (12 cycles or more)
Number of subjects: 16
Study 25828745 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypomethylating agents (HMA) therapy (fewer than 12 cycles)
Number of subjects: 16
Study 25828745 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with poor-risk cytogenetics
Number of subjects: 16
Study 25828745 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without poor-risk cytogenetics
Number of subjects: 16
Study 23417031 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (up to 160mg daily)
Number of subjects: 0
Study 23417031 — intervention group
Group type: COMPARATOR
Intervention: No valsartan (control)
Number of subjects: 0
Study 21036583 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive leaf extract (500 mg twice daily)
Number of subjects: 0
Study 21036583 — intervention group
Group type: COMPARATOR
Intervention: Captopril (12.5 mg twice daily, titrated to 25 mg if necessary)
Number of subjects: 0
Study 21036583 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive leaf extract
Number of subjects: 0
Study 21036583 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study 19812260 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Number of subjects: 1359
Study 19812260 — intervention group
Group type: COMPARATOR
Intervention: Menactra
Number of subjects: 1359
Study 18080399 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc combined with optimized background therapy (OBT)
Number of subjects: 0
Study 18080399 — intervention group
Group type: COMPARATOR
Intervention: Maraviroc
Number of subjects: 0
Study 15535413 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported medication adherence
Number of subjects: 131
Study 15535413 — intervention group
Group type: EXPERIMENTAL
Intervention: Undetectable PI concentrations
Number of subjects: 131
Study 15535413 — intervention group
Group type: COMPARATOR
Intervention: Frequent HIV RNA measurement group
Number of subjects: 131
Study 15535413 — intervention group
Group type: EXPERIMENTAL
Intervention: Detectable PI concentrations
Number of subjects: 131
Study 15535413 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HIV RNA level
Number of subjects: 131
Study 11442282 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (Lot 1)
Number of subjects: 24
Study 11442282 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (Lot 2)
Number of subjects: 24
Study 11442282 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (Lot 3)
Number of subjects: 24
Study 11442282 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (all lots)
Number of subjects: 24
Study 11442282 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (females)
Number of subjects: 24
Study 9505274 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm infant formula from discharge to 6 months (group A)
Number of subjects: 3
Study 9505274 — intervention group
Group type: COMPARATOR
Intervention: Term formula from discharge to 6 months (group B)
Number of subjects: 3
Study 9505274 — intervention group
Group type: COMPARATOR
Intervention: Preterm formula (discharge to term) and term formula (term to 6 months) (group C)
Number of subjects: 3
Study 9505274 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of nutrient intake
Number of subjects: 3
Study 8312411 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid dialysis
Number of subjects: 7
Study 8312411 — intervention group
Group type: COMPARATOR
Intervention: Dextrose dialysis
Number of subjects: 7
Study 2841053 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol 50-100 mg/day
Number of subjects: 20
Study 2841053 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril 5-20 mg/day
Number of subjects: 20
Study 2841053 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 2841053 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 20
Study 2841053 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril
Number of subjects: 20
Study 2841053 — intervention group
Group type: EXPERIMENTAL
Intervention: furosemide
Number of subjects: 20
Study 31400077 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological causal explanation
Number of subjects: 229
Study 31400077 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial causal explanation
Number of subjects: 229
Study 31400077 — intervention group
Group type: COMPARATOR
Intervention: Non-causal control
Number of subjects: 229
Study 29896844 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical training (two weekly sessions for 26 weeks)
Number of subjects: 60
Study 29896844 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physical training)
Number of subjects: 60
Study 28253045 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative physical activity counseling for 6 weeks, encouraging daily walking at moderate intensity in bouts ≥ 10 minutes during morning hours
Number of subjects: 33
Study 28253045 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants whose longest MVPA bouts occurred during morning hours (n = 11)
Number of subjects: 33
Study 25923718 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the anterior cingulate cortex (ACC)
Number of subjects: 8
Study 25923718 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the dorsal premotor cortex (dPM)
Number of subjects: 8
Study 25923718 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex (MC)
Number of subjects: 8
Study 25923718 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 8
Study 25923718 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the supplementary motor area (SMA)
Number of subjects: 8
Study 22936619 — intervention group
Group type: EXPERIMENTAL
Intervention: TAXUS or Express bare metal stents
Number of subjects: 43
Study 22936619 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiographic thrombus (+)
Number of subjects: 43
Study 22936619 — intervention group
Group type: COMPARATOR
Intervention: Angiographic thrombus (-)
Number of subjects: 43
Study 22204173 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) therapy
Number of subjects: 31
Study 22204173 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant mode of TENS therapy
Number of subjects: 31
Study 22204173 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst mode of TENS therapy
Number of subjects: 31
Study 19759166 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg soy hypocotyl aglycone isoflavones plus calcium and vitamin D
Number of subjects: 403
Study 19759166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study 16463415 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy in a warm, waist-high pool (3 weekly sessions for 12 weeks)
Number of subjects: 34
Study 16463415 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy in a warm, waist-high pool
Number of subjects: 34
Study 16463415 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study 14760123 — intervention group
Group type: EXPERIMENTAL
Intervention: ASCT-rituximab
Number of subjects: 20